HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration.

Abstract
Adeno-associated virus (AAV) has attracted considerable interest as a potential vector for gene therapy because of its wide host range, high transduction efficiency, and lack of cytopathogenicity. In this experiment, we evaluated the efficacy of AAV vector containing the herpes simplex virus thymidine kinase (HSV-tk) gene on human gliomas transplanted into the brain of nude mice. Complete regression of the tumors was observed after multiple AAV-tk injections followed by intraperitoneal ganciclovir (GCV) administration, and the survival of mice treated with AAV-tk vector and GCV administration was markedly prolonged. These results suggest that AAV-tk vectors may be useful for gene therapy against malignant gliomas in humans.
AuthorsM Mizuno, J Yoshida, P Colosi, G Kurtzman
JournalJapanese journal of cancer research : Gann (Jpn J Cancer Res) Vol. 89 Issue 1 Pg. 76-80 (Jan 1998) ISSN: 0910-5050 [Print] Japan
PMID9510479 (Publication Type: Journal Article)
Chemical References
  • Thymidine Kinase
  • Ganciclovir
Topics
  • Animals
  • Brain Neoplasms (mortality, therapy)
  • Dependovirus (genetics)
  • Female
  • Ganciclovir (administration & dosage, therapeutic use)
  • Genetic Therapy (methods)
  • Genetic Vectors
  • Glioma (mortality, therapy)
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Neoplasm Transplantation
  • Simplexvirus (enzymology, genetics)
  • Survival Rate
  • Thymidine Kinase (administration & dosage, genetics)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: